A CD8+ T-lymphocyte-mediated and CD4+ T-lymphocyte-independent autoimmune diabetes of early onset in transgenic mice

Diabetologia. 1994 Dec;37(12):1277-9. doi: 10.1007/BF00399802.

Abstract

While transgenic mice expressing tumour necrosis factor-alpha under the control of the beta-cell-specific insulin promoter display a marked lymphocytic infiltration of the islets, they never develop insulin-dependent diabetes mellitus (IDDM). In striking contrast, "double" transgenic mice whose beta cells express both tumour necrosis factor-alpha as well as the co-stimulatory B7-1 molecule all develop IDDM at an early age. Furthermore, administration of anti-CD8 but not anti-CD4 immunoglobulins prevents diabetes onset. These results indicate that while tumour necrosis factor-alpha induced lymphocytic infiltration is not sufficient to effect beta-cell destruction, locally co-stimulated islet-infiltrating CD8+ T lymphocytes could play a critical role in the development of IDDM.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Autoimmune Diseases / immunology*
  • Autoimmune Diseases / prevention & control
  • B7-1 Antigen / biosynthesis*
  • B7-1 Antigen / immunology
  • Blood Glucose / metabolism
  • CD4 Antigens / immunology*
  • CD4-Positive T-Lymphocytes / immunology*
  • CD8 Antigens / immunology*
  • CD8-Positive T-Lymphocytes / immunology*
  • Diabetes Mellitus, Type 1 / immunology*
  • Diabetes Mellitus, Type 1 / prevention & control
  • Female
  • Immunoglobulins, Intravenous / pharmacology
  • Islets of Langerhans / immunology
  • Male
  • Mice
  • Mice, Transgenic
  • Tumor Necrosis Factor-alpha / biosynthesis*
  • Tumor Necrosis Factor-alpha / immunology

Substances

  • B7-1 Antigen
  • Blood Glucose
  • CD4 Antigens
  • CD8 Antigens
  • Immunoglobulins, Intravenous
  • Tumor Necrosis Factor-alpha